{
  "primary": "PRPF19",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "The E3 ligase PRPF19 interacts with mutant ATXN3, targeting it for ubiquitination and degradation.",
  "functions": [
    {
      "function": "Mutant ATXN3 Degradation",
      "arrow": "activates",
      "cellular_process": "Pre-mRNA processing factor 19 (PRPF19) functions as an E3 ubiquitin ligase that recognizes and binds to polyQ-expanded mutant ATXN3. Upon binding, PRPF19 catalyzes the attachment of poly-ubiquitin chains to mutant ATXN3, thereby marking it for degradation by the ubiquitin-proteasome system (UPS).",
      "effect_description": "PRPF19 plays a crucial role in cellular quality control by facilitating the clearance of toxic, misfolded mutant ATXN3. This action reduces the cellular burden of the pathogenic protein, suppresses the formation of aggregates, and mitigates downstream cytotoxicity and neurodegeneration.",
      "biological_consequence": [
        "PRPF19 recognizes and binds to misfolded, polyQ-expanded ATXN3 in the nucleus → PRPF19 mediates the poly-ubiquitination of mutant ATXN3 → Ubiquitinated ATXN3 is targeted to the 26S proteasome → Proteasomal degradation leads to reduced levels of mutant ATXN3 → Cellular toxicity and neurodegeneration are suppressed."
      ],
      "specific_effects": [
        "Overexpression of PRPF19 promotes the poly-ubiquitination and subsequent degradation of mutant ATXN3.",
        "The nuclear localization of PRPF19 is essential for its ability to modulate the levels and toxicity of mutant ATXN3.",
        "The neuroprotective effect of PRPF19 is counteracted by its interacting partner, Exoc7, which regulates the E3 ligase function of PRPF19."
      ],
      "evidence": [
        {
          "paper_title": "A fine balance between Prpf19 and Exoc7 in achieving degradation of aggregated protein and suppression of cell death in spinocerebellar ataxia type 3",
          "journal": "Cell Death & Disease",
          "year": 2021,
          "relevant_quote": "In this study, we identified an E3 ligase, pre-mRNA processing factor 19 (Prpf19/prp19), that modulates expanded ataxin-3 (ATXN3-polyQ), disease protein of SCA3, induced neurodegeneration in both mammalian and Drosophila disease models. We further showed that Prpf19/prp19 promotes poly-ubiquitination and degradation of mutant ATXN3-polyQ protein.",
          "pmid": "33542212"
        }
      ],
      "pmids": [
        "33542212"
      ],
      "interaction_effect": "activates",
      "interaction_direction": "primary_to_main",
      "function_effect": "activation"
    }
  ],
  "arrow": "activates",
  "direction": "main_to_primary",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "activates"
    ]
  },
  "is_valid": true,
  "mechanism_correction": null,
  "mechanism": "Pre-mRNA processing factor 19 (PRPF19) functions as an E3 ubiquitin ligase that recognizes and binds to polyQ-expanded mutant ATXN3. Upon binding, PRPF19 catalyzes the attachment of poly-ubiquitin chains to mutant ATXN3, thereby marking it for degradation by the ubiquitin-proteasome system (UPS).",
  "effect": "PRPF19 plays a crucial role in cellular quality control by facilitating the clearance of toxic, misfolded mutant ATXN3. This action reduces the cellular burden of the pathogenic protein, suppresses the formation of aggregates, and mitigates downstream cytotoxicity and neurodegeneration.",
  "summary": "ATXN3 activates PRPF19 to modulate mutant atxn3 degradation, ultimately affecting cellular toxicity and neurodegeneration are suppressed.",
  "evidence": [
    {
      "paper_title": "A fine balance between Prpf19 and Exoc7 in achieving degradation of aggregated protein and suppression of cell death in spinocerebellar ataxia type 3",
      "journal": "Cell Death & Disease",
      "year": 2021,
      "relevant_quote": "In this study, we identified an E3 ligase, pre-mRNA processing factor 19 (Prpf19/prp19), that modulates expanded ataxin-3 (ATXN3-polyQ), disease protein of SCA3, induced neurodegeneration in both mammalian and Drosophila disease models. We further showed that Prpf19/prp19 promotes poly-ubiquitination and degradation of mutant ATXN3-polyQ protein."
    }
  ],
  "arrow_notation": "ATXN3 --activates--> PRPF19:",
  "protein_a": "ATXN3",
  "protein_b": "PRPF19",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-11-29T11:33:49.700540Z",
  "last_updated": "2025-11-29T11:33:49.700540Z"
}